6-K ·Filed Sep 15, 2026
Notable filing: 6-K
Actionable Insight • Neutral
Monitor for the release of the actual 6-K content or subsequent filings (e.g., earnings, clinical updates) for material information. Until then, no immediate trading action is warranted.
Latest settled — T+20d
QNTM ▼ -16.47% at T+20d
NEUTRAL call -16.47% · α vs SPY -19.45% · entry $3.46 → $2.89
Latest observation: T+28 -27.76% FF3 residual α
T+1d
+3.76%
call +3.76% · α +3.43%
$3.59
settled 6w ago
T+5d
+5.78%
call +5.78% · α +4.96%
$3.66
settled 5w ago
T+20d
-16.47%
call -16.47% · α -19.45%
$2.89
settled 14d ago
T+60d
Pending
in 6w
Price Chart
Loading chart...
Executive Summary
Quantum Biopharma Ltd. filed a Form 6-K with the SEC. The document content was unavailable for analysis, so the filing's specific disclosures could not be reviewed. The filing is routine in nature with no material financial or operational details available.
Key Facts
- Form 6-K filed by Quantum Biopharma Ltd. (QNTM)
- Document content unavailable for analysis
- No financial figures or material events disclosed in available metadata
Financial Impact
Undisclosed — no financial data available in the filing.
Risk Factors
- Lack of visibility into filing content may hide material disclosures
- Biotech sector volatility could amplify any undisclosed news
Market Snapshot
Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
86% bullish (7 analysts)
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001171843-26-006047 |
| Document: f6k_091426.htm | 0001171843-26-006047 |
| Document: 0001171843-26-006047-index-headers.html | 0001171843-26-006047 |
| Document: 0001171843-26-006047-index.html | 0001171843-26-006047 |
| Document: 0001171843-26-006047.txt | 0001171843-26-006047 |
30 reports for QNTM
44% Hit rate @ T+20 Went positive at some point 6 of 9 best @ T+1▲ +52.58%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 8, 2026 19d ago | 6-K | $3.11 | awaiting T+20 | — | $2.21 (−28.94%) |
Oct 6, 2026 21d ago | 6-K | $3.09 | awaiting T+20 | — | $2.21 (−28.48%) |
Oct 6, 2026 21d ago | Press Release | $3.09 | awaiting T+20 | — | $2.21 (−28.48%) |
Oct 5, 2026 21d ago | SC 13G/A | $3.27 | awaiting T+20 | — | $2.21 (−32.42%) |
Sep 24, 2026 4w ago | 6-K | $4.00 $2.27 | ▼ −43.25% | ▼ −42.83% | $2.21 (−44.75%) |
Sep 17, 2026 5w ago | 6-K | $3.72 $2.71 | ▼ −27.15% | ▼ −28.36% | $2.21 (−40.59%) |
Sep 17, 2026 5w ago | 6-K | $3.72 $2.71 | ▼ −27.15% | ▼ −28.36% | $2.21 (−40.59%) |
Sep 15, 2026 6w ago | 6-K | $3.46 $2.89 | ▼ −16.47% | ▼ −19.45% | $2.21 (−36.13%) |
Sep 1, 2026 7w ago | 6-K | $3.08 $3.60 | ▲ +16.88% | ▲ +17.21% | $2.21 (−28.25%) |
Sep 1, 2026 7w ago | Press Release | $3.08 $3.60 | ▲ +16.88% | ▲ +17.21% | $2.21 (−28.25%) |
Showing 10 of 30
US Market Status
Market Closed — Opens in 49m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers